COMPANIES
Canopus
-
Recent Articles
- Canopus secures WARF patents15 July 2008
Canopus BioPharma, Inc., a biotechnology company developing pharmaceutical products and assay methods for patients suffering from infectious disease, radiation sickness, cancer and addiction, has signed a licensing agreement with the Wisconsin Alumni Research Foundation (WARF), an organisation serving the University of Wisconsin-Madison scientific community by patenting the discoveries of UW-Madison researchers and licensing these technologies to companies worldwide.
- Broadcast technology supply valued at $11bn1 February 2007
The market is forecast to grow at 11% per annum to be worth $17.5bn by 2010.
- Canopus secures WARF patents15 July 2008
All markets data located on
ArabianBusiness.com is subject to the ArabianBusiness.com Terms & Conditions. Content should be used for general information use only.
Charts and statics display delayed intraday data. Share price information may be rounded up/down and therefore may not be entirely accurate
Selected data supplied by Reuters Limited. Click for Restrictions.